HAWKINS INC Revenue Disclosure
| Fiscal Year Ended March 29, 2026: | |||||||||||||||||||||||
| (In thousands) | Water Treatment | Food and Health Sciences | Industrial Solutions | Total | |||||||||||||||||||
Manufactured, blended or repackaged products (1) | $ | 488,620 | $ | — | $ | 167,710 | $ | 656,330 | |||||||||||||||
Bulk products (2) | 49,575 | — | 46,579 | 96,154 | |||||||||||||||||||
| Nutrition | — | 137,986 | — | 137,986 | |||||||||||||||||||
| Food | — | 99,278 | — | 99,278 | |||||||||||||||||||
| Pharmaceutical | — | 27,871 | — | 27,871 | |||||||||||||||||||
| Agricultural | — | 52,565 | — | 52,565 | |||||||||||||||||||
| Other | 5,108 | 3,000 | 5,404 | 13,512 | |||||||||||||||||||
| Total external customer sales | $ | 543,303 | $ | 320,700 | $ | 219,693 | $ | 1,083,696 | |||||||||||||||
| Fiscal Year Ended March 30, 2025: | |||||||||||||||||||||||
| (In thousands) | Water Treatment | Food and Health Sciences | Industrial Solutions | Total | |||||||||||||||||||
Manufactured, blended or repackaged products (1) | $ | 400,849 | $ | — | $ | 152,087 | $ | 552,936 | |||||||||||||||
Bulk products (2) | 39,977 | — | 47,885 | 87,862 | |||||||||||||||||||
| Nutrition | — | 144,434 | — | 144,434 | |||||||||||||||||||
| Food | — | 103,403 | — | 103,403 | |||||||||||||||||||
| Pharmaceutical | — | 25,864 | — | 25,864 | |||||||||||||||||||
| Agricultural | — | 45,727 | — | 45,727 | |||||||||||||||||||
| Other | 5,663 | 3,132 | 5,410 | 14,205 | |||||||||||||||||||
| Total external customer sales | $ | 446,489 | $ | 322,560 | $ | 205,382 | $ | 974,431 | |||||||||||||||
| Fiscal Year Ended March 31, 2024: | |||||||||||||||||||||||
| (In thousands) | Water Treatment | Food and Health Sciences | Industrial Solutions | Total | |||||||||||||||||||
Manufactured, blended or repackaged products (1) | $ | 327,188 | $ | — | $ | 163,655 | $ | 490,843 | |||||||||||||||
Bulk products (2) | 32,349 | — | 50,732 | 83,081 | |||||||||||||||||||
| Nutrition | — | 145,460 | — | 145,460 | |||||||||||||||||||
| Food | — | 114,516 | — | 114,516 | |||||||||||||||||||
| Pharmaceutical | — | 20,546 | — | 20,546 | |||||||||||||||||||
| Agricultural | — | 51,456 | — | 51,456 | |||||||||||||||||||
| Other | 3,752 | 2,582 | 6,926 | 13,260 | |||||||||||||||||||
| Total external customer sales | $ | 363,289 | $ | 334,560 | $ | 221,313 | $ | 919,162 | |||||||||||||||
Want the next HAWKINS INC revenue disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment HAWKINS INC's next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | May 13, 2026 | Showing above |
| 2025 | May 14, 2025 | |
| 2024 | May 15, 2024 | |
| 2023 | May 17, 2023 | |
| 2022 | May 18, 2022 | |
| 2021 | Jun 2, 2021 | |
| 2020 | May 20, 2020 | |
| 2019 | May 23, 2019 | |
About Revenue Disclosures
Revenue disclosures under ASC 606 explain how a company identifies performance obligations, allocates transaction prices, and determines when revenue is recognized. This section is essential for understanding whether reported revenue reflects genuine economic activity or aggressive accounting choices. Analysts examine the mix of point-in-time versus over-time recognition, which directly affects revenue timing and comparability.
Key signals: rising contract liabilities (deferred revenue) suggest strong future revenue visibility, while declining contract assets may indicate slowing project milestones. Watch for variable consideration estimates — rebates, returns, and performance bonuses that require management judgment. Significant changes in disaggregated revenue by geography or product line can reveal shifting business mix before it appears in headline numbers. Compare revenue growth against contract liability growth to assess sustainability, and scrutinize any changes in the timing of recognition that coincide with earnings pressure.